Early binding of anti-amyloid antibodies to CAA drives complement activation, inflammation and ARIA in mice.
Saved in:
| Title: | Early binding of anti-amyloid antibodies to CAA drives complement activation, inflammation and ARIA in mice. |
|---|---|
| Authors: | Bathini P; Brigham and Women's Hospital, Boston, MA, USA. pbathini@bwh.harvard.edu.; Harvard Medical School, Boston, MA, USA. pbathini@bwh.harvard.edu., Schilling S; Fraunhofer Institute for Cell Therapy and Immunology, Halle (Saale), Germany.; Anhalt University of Applied Sciences, Köthen, Germany., Rahfeld JU; Fraunhofer Institute for Cell Therapy and Immunology, Halle (Saale), Germany.; Anhalt University of Applied Sciences, Köthen, Germany., Holtzman DM; Department of Neurology, Hope Center for Neurological Disorders, Knight Alzheimer's Disease Research Center, Washington University School of Medicine, St. Louis, MO, USA., Saido TC; RIKEN Center for Brain Science, Wako, Japan., Lemere CA; Brigham and Women's Hospital, Boston, MA, USA. clemere@bwh.harvard.edu.; Harvard Medical School, Boston, MA, USA. clemere@bwh.harvard.edu. |
| Source: | Molecular neurodegeneration [Mol Neurodegener] 2026 Jun 26. Date of Electronic Publication: 2026 Jun 26. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 101266600 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1750-1326 (Electronic) Linking ISSN: 17501326 NLM ISO Abbreviation: Mol Neurodegener Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
